Xiphora Biopharma Consulting is a UK-based

consultancy offering nonclinical services to the

pharmaceutical sector.


The principal, David Snodin, PhD, is a regulatory pharmacotoxicologist with over 
30 years’ experience in industry, government and  consulting. 
As well as general nonclinical consulting, we specialize in dealing with issues at 
the Quality-Safety interface, particularly impurity qualification and the safety 
assessment of excipients.
Our services include Nonclinical Drug Development and Specialist Consulting.

For more information please select Services from the menu above.